KINGDON CAPITAL MANAGEMENT, L.L.C. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q2 2021$8,157,000
+325.1%
65,000
+333.3%
0.94%
+354.3%
Q4 2020$1,919,000
-93.0%
15,000
-93.9%
0.21%
-93.3%
Q3 2020$27,485,000
+12.1%
244,249
-5.1%
3.09%
+38.4%
Q2 2020$24,508,000
+27.1%
257,249
+19.9%
2.23%
-36.8%
Q1 2020$19,281,000214,5383.53%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders